Although the primary focus of this study is on the role of IL-31 in modulating response to immune checkpoint therapy, our data also suggest that IL-31 alone does not directly promote tumor growth, as exogenous IL-31 had no significant effect in the murine model without immunotherapy. The gene discussed is IL31; the disease is neoplasm.